Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.
about
Characterization of a novel Zn²⁺-dependent intrinsic imipenemase from Pseudomonas aeruginosaA large sustained endemic outbreak of multiresistant Pseudomonas aeruginosa: a new epidemiological scenario for nosocomial acquisition.Activity of a new antipseudomonal cephalosporin, CXA-101 (FR264205), against carbapenem-resistant and multidrug-resistant Pseudomonas aeruginosa clinical strainsSequence types 235, 111, and 132 predominate among multidrug-resistant pseudomonas aeruginosa clinical isolates in Croatia.Aminoglycoside modifying enzymes.Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study.AmpG inactivation restores susceptibility of pan-beta-lactam-resistant Pseudomonas aeruginosa clinical strains.Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.Pseudomonas aeruginosa: resistance to the maxDetection of Metallo-Beta Lactamases Among Carbapenem-Resistant Pseudomonas aeruginosa.The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.Diversity and antibiotic resistance profiles of Pseudomonads from a hospital wastewater treatment plant.Prospective multicenter study of the impact of carbapenem resistance on mortality in Pseudomonas aeruginosa bloodstream infections.Alterations of OprD in carbapenem-intermediate and -susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish multicenter study.Diverse mobilized class 1 integrons are common in the chromosomes of pathogenic Pseudomonas aeruginosa clinical isolates.Overproduction of active efflux pump and variations of OprD dominate in imipenem-resistant Pseudomonas aeruginosa isolated from patients with bloodstream infections in Taiwan.VIM-2-producing multidrug-resistant Pseudomonas aeruginosa ST175 clone, SpainPan-β-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities.First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.Occurrence and characteristics of class 1 and 2 integrons in Pseudomonas aeruginosa isolates from patients in southern China.Antimicrobial resistance in hospitals: how concerned should we be?Characterization of the new AmpC β-lactamase FOX-8 reveals a single mutation, Phe313Leu, located in the R2 loop that affects ceftazidime hydrolysis.Nosocomial outbreak of a non-cefepime-susceptible ceftazidime-susceptible Pseudomonas aeruginosa strain overexpressing MexXY-OprM and producing an integron-borne PSE-1 betta-lactamase.AmpC beta-lactamases.Penicillin-Binding Protein 3 Is Essential for Growth of Pseudomonas aeruginosa.Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence.Providing β-lactams a helping hand: targeting the AmpC β-lactamase induction pathway.Environmental microbiota represents a natural reservoir for dissemination of clinically relevant metallo-beta-lactamases.Detection of AmpC-β-lactamases producing isolates among carbapenem resistant P. aeruginosa isolated from burn patient.Comparison of local features from two Spanish hospitals reveals common and specific traits at multiple levels of the molecular epidemiology of metallo-β-lactamase-producing Pseudomonas spp.N152G, -S, and -T substitutions in CMY-2 β-lactamase increase catalytic efficiency for cefoxitin and inactivation rates for tazobactam.Presence of VIM-Positive Pseudomonas Species in Chickens and Their Surrounding Environment.Nosocomial dissemination of VIM-2-producing ST235 Pseudomonas aeruginosa in Lithuania.Application of the multifactor dimensionality reduction method in evaluation of the roles of multiple genes/enzymes in multidrug-resistant acquisition in Pseudomonas aeruginosa strains.Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones.Molecular detection of metallo-β-lactamase gene blaVIM-1 in imipenem-resistant Pseudomonas aeruginosa strains isolated from hospitalized patients in the hospitals of Isfahan.Activity of a new cephalosporin, CXA-101 (FR264205), against beta-lactam-resistant Pseudomonas aeruginosa mutants selected in vitro and after antipseudomonal treatment of intensive care unit patients.Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.NagZ inactivation prevents and reverts beta-lactam resistance, driven by AmpD and PBP 4 mutations, in Pseudomonas aeruginosaMechanisms responsible for the emergence of carbapenem resistance in Pseudomonas aeruginosa.
P2860
Q28492716-F2C7B31A-3198-496B-862D-7F6C35F70EBBQ31034219-33B7AF33-7F4D-459E-AB38-16BF3CB7E334Q33613660-657C82B4-932F-48CF-9049-AEC53378C901Q34298890-3EFACDA3-A312-4F55-8874-EF41847B3719Q34354185-D52145FE-1E73-43F9-B802-3B5E243E8104Q34932869-42DF4BF9-37CF-49F1-ADAE-5B13C0C536F8Q34933120-30E6ABAF-34E4-4E52-A094-11F7DE667650Q35007624-1BD29E35-788C-4A92-BF7B-53BA6E07C68DQ35084559-85A1C2CB-AEF3-458B-951F-2E4368C4CDC0Q35094250-84191271-A17C-4C24-B64E-AE709DE65CA6Q35482558-E81F6D54-A38F-4DC2-9696-916DD8046635Q35749010-985C8759-5263-4898-912F-804B88E0257FQ35806150-6453880F-0F87-4BA3-A5F9-95028E4DB0E6Q35867456-6801EB9B-AD4D-43A2-9DCF-FDDF206EB37DQ35867461-67109952-6910-434F-BD9C-474293514172Q36050858-7C0B8E0B-CC2A-42CC-BF1C-A7F21849DD26Q36147987-1F24EE9F-D7F9-45CD-8768-A20152567B6AQ36172484-3FC94263-93E3-412C-B2EC-0A5FD9569E6FQ36949459-07611FF8-A536-4E6F-8A24-A346180A7B72Q37051489-E3C9AA36-2F95-402D-827F-AD924458F50AQ37088893-32F0D296-E665-4D8E-8A82-4FB206599F2FQ37263714-6A891119-F4A4-4BA0-BBD8-BE070A3B1FCEQ37302114-398E1A0B-E27F-46F8-B5D8-ABE701B3F19BQ37366249-3CB3326A-4981-4424-B6FC-9C72855218C5Q37538678-B29DB56E-D752-4EF5-AA9A-3152C9A133DCQ37643058-E439E1E3-22C8-48A0-B1F9-961A5EF9BC2CQ37961906-57255440-0A65-456A-88A2-E62E919645CEQ38726708-3921BBE7-942B-468D-BCBA-B653C5F401D4Q39237831-C26A9C79-598B-4A8A-84A1-D5F070109A16Q39682878-760E7133-BD82-4437-8680-E103C1EFCA77Q39767332-FD39B94E-8CD7-4688-97A4-610C8646AD7DQ40239321-89B56552-B8E2-4607-B3C2-C7040931BC20Q40882363-D412BBD4-D9E1-485F-8C9F-7D613B14DDA5Q41076559-59AA434D-7261-43DE-BF0F-DFB9E73F3313Q41183478-B3225B87-3478-4C5F-84B2-4C27F49CBE60Q41390555-E5D8C61A-96F2-4B7E-A9DF-1C700D04C9E4Q41839265-193E66A6-12DF-4D57-A545-B653C71A94DAQ42111506-153ED16C-85C7-4D13-8044-4F13C6F21766Q42430253-25AFEED8-BB94-47E1-9D11-E4F28A2A8A72Q42547162-944969F4-F312-4206-88B0-3C48F5E16DF3
P2860
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Molecular epidemiology and mec ...... olates from Spanish hospitals.
@ast
Molecular epidemiology and mec ...... olates from Spanish hospitals.
@en
type
label
Molecular epidemiology and mec ...... olates from Spanish hospitals.
@ast
Molecular epidemiology and mec ...... olates from Spanish hospitals.
@en
prefLabel
Molecular epidemiology and mec ...... olates from Spanish hospitals.
@ast
Molecular epidemiology and mec ...... olates from Spanish hospitals.
@en
P2093
P2860
P50
P356
P1476
Molecular epidemiology and mec ...... olates from Spanish hospitals.
@en
P2093
E Cercenado
O Gutiérrez
P2860
P304
P356
10.1128/AAC.00810-07
P407
P577
2007-10-15T00:00:00Z